Neonc Technologies Holdings, Inc. $NTHI Shares Bought by HighPoint Advisor Group LLC

HighPoint Advisor Group LLC lifted its position in shares of Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) by 20.5% during the 4th quarter, HoldingsChannel reports. The fund owned 1,144,640 shares of the company’s stock after purchasing an additional 194,408 shares during the period. HighPoint Advisor Group LLC’s holdings in Neonc Technologies were worth $9,466,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of NTHI. Bank of America Corp DE acquired a new position in Neonc Technologies in the 2nd quarter worth about $801,000. Vanguard Group Inc. acquired a new position in Neonc Technologies in the 3rd quarter worth about $1,279,000. Royal Bank of Canada acquired a new position in Neonc Technologies in the 1st quarter worth about $247,000. Foundations Investment Advisors LLC acquired a new position in Neonc Technologies in the 3rd quarter worth about $100,000. Finally, Westmount Partners LLC raised its holdings in Neonc Technologies by 7.7% in the 4th quarter. Westmount Partners LLC now owns 43,320 shares of the company’s stock worth $358,000 after purchasing an additional 3,112 shares during the period.

Neonc Technologies Stock Performance

NTHI opened at $5.50 on Tuesday. Neonc Technologies Holdings, Inc. has a twelve month low of $3.20 and a twelve month high of $12.99. The company has a 50-day moving average price of $6.76 and a 200 day moving average price of $8.27.

Analysts Set New Price Targets

A number of research firms recently weighed in on NTHI. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Neonc Technologies in a report on Friday, March 27th. BTIG Research began coverage on Neonc Technologies in a report on Friday, April 24th. They issued a “buy” rating and a $15.00 price target for the company. Finally, Zacks Research raised Neonc Technologies to a “hold” rating in a report on Wednesday, January 14th. One analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $15.00.

Insider Buying and Selling at Neonc Technologies

In related news, President Amir F. Heshmatpour purchased 20,000 shares of Neonc Technologies stock in a transaction that occurred on Thursday, April 2nd. The stock was purchased at an average price of $6.09 per share, for a total transaction of $121,800.00. Following the transaction, the president directly owned 3,012,000 shares in the company, valued at approximately $18,343,080. This trade represents a 0.67% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. In the last three months, insiders have bought 80,700 shares of company stock worth $423,590.

About Neonc Technologies

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.